ZARZA We are Zarza, the prestigious firm behind major projects in information technology.

Seminal Trial Series: Crizotinib in PROFILE 1001

Lung Cancer Considered

06/08/2024 56 min

Listen "Seminal Trial Series: Crizotinib in PROFILE 1001"

Descargar episodio Ver en sitio original

Episode Synopsis

Seminal Trial Series: Crizotinib in PROFILE 1001 by IASLC

More episodes of the podcast Lung Cancer Considered

Lung Cancer Considered: • Rising Above: The Lung Cancer Hope Summit 21/10/2025

LCC in Greek: WCLC 2025 Highlights 10/10/2025

FDA Approval: Maintenance Lurbinectedin for SCLC 07/10/2025

LCC in Arabic: WCLC 2025 Highlights 03/10/2025

Lung Cancer Considered in Dutch: Targeting EGFR NSCLC 03/10/2025

Lung Cancer Considered: Targeting EGFR NSCLC 03/10/2025

LCC in Korean: WCLC 2025 Highlights 30/09/2025

IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy 26/09/2025

LCC in Mandarin: WCLC 2025 Highlights with Experts from Taiwan 18/09/2025

LCC in Portuguese: WCLC 2025 Highlights 16/09/2025

Ver todos los episodios